Your browser doesn't support javascript.
loading
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic.
Zanghì, Aurora; Avolio, Carlo; Signoriello, Elisabetta; Abbadessa, Gianmarco; Cellerino, Maria; Ferraro, Diana; Messina, Christian; Barone, Stefania; Callari, Graziella; Tsantes, Elena; Sola, Patrizia; Valentino, Paola; Granella, Franco; Patti, Francesco; Lus, Giacomo; Bonavita, Simona; Inglese, Matilde; D'Amico, Emanuele.
Afiliação
  • Zanghì A; UOC Neurology, Sant'Elia Hospital, Caltanissetta, Italy.
  • Avolio C; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Signoriello E; Head of Multiple Sclerosis Center, Dept. of Neurosciences, Policlinico Riuniti Hospital, Foggia, Italy.
  • Abbadessa G; Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
  • Cellerino M; Dipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.
  • Ferraro D; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Mother-Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • Messina C; University of Modena and Reggio Emilia, Modena, Italy.
  • Barone S; Department "G.F. Ingrassia", MS Center University of Catania, Catania, Italy.
  • Callari G; Azienda Ospedaliera Universitaria "Mater Domini", Catanzaro, Italy.
  • Tsantes E; Institute Foundation "G. Giglio", Cefalù, Italy.
  • Sola P; Department of General Medicine, Parma University Hospital, Parma, Italy.
  • Valentino P; University of Modena and Reggio Emilia, Modena, Italy.
  • Granella F; Azienda Ospedaliera Universitaria "Mater Domini", Catanzaro, Italy.
  • Patti F; Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Lus G; Multiple Sclerosis Centre, Department of General Medicine, Parma University Hospital, Parma, Italy.
  • Bonavita S; Department "G.F. Ingrassia", MS Center University of Catania, Catania, Italy.
  • Inglese M; Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
  • D'Amico E; Dipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138, Naples, Italy.
Neurotherapeutics ; 19(5): 1535-1545, 2022 09.
Article em En | MEDLINE | ID: mdl-36036858
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / COVID-19 / Esclerose Múltipla Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / COVID-19 / Esclerose Múltipla Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article